The Current Ratio as of December 2024 (TTM) for IDEAYA Biosciences, Inc. (IDYA) is 22.93

According to IDEAYA Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 22.93. This represents a change of 3.62% compared to the average of 22.13 of the last 4 quarters.

IDEAYA Biosciences, Inc. (IDYA) Historical Current Ratio (quarterly & annually)

How has IDYA Current Ratio performed in the past?

The mean historical Current Ratio of IDEAYA Biosciences, Inc. over the last ten years is 11.60. The current 22.93 Current Ratio has changed 19.67% with respect to the historical average. Over the past ten years (40 quarters), IDYA's Current Ratio was at its highest in in the March 2024 quarter at 28.42. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

IDEAYA Biosciences, Inc. (IDYA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of IDEAYA Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IDEAYA Biosciences, Inc. (IDYA) Average Current Ratio

How has IDYA Current Ratio performed in the past?

The current Current Ratio of IDEAYA Biosciences, Inc. (IDYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IDEAYA Biosciences, Inc. (IDYA) Current Ratio vs. Peers

How is IDYA’s Current Ratio compared to its peers?

IDEAYA Biosciences, Inc.’s Current Ratio is greater than AnaptysBio, Inc. (10.23), greater than MeiraGTx Holdings plc (2.34), greater than Keros Therapeutics, Inc. (19.03), greater than Homology Medicines, Inc. (4.19), less than Ventyx Biosciences, Inc. (23.52), greater than Protagonist Therapeutics, Inc. (10.70), greater than Verona Pharma plc (13.03), greater than Syndax Pharmaceuticals, Inc. (6.99), greater than Cerevel Therapeutics Holdings, Inc. (10.22), greater than Avidity Biosciences, Inc. (17.76), greater than Revolution Medicines, Inc. (14.24), greater than Day One Biopharmaceuticals, Inc. (14.62), greater than SpringWorks Therapeutics, Inc. (6.16), less than Terns Pharmaceuticals, Inc. (32.99), greater than Acumen Pharmaceuticals, Inc. (10.43), greater than Amylyx Pharmaceuticals, Inc. (4.55), less than MoonLake Immunotherapeutics (25.51), greater than X4 Pharmaceuticals, Inc. (4.89), greater than Inozyme Pharma, Inc. (7.68), greater than VectivBio Holding AG (9.14),

Build a custom stock screener for IDEAYA Biosciences, Inc. (IDYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IDEAYA Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IDEAYA Biosciences, Inc. (IDYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IDEAYA Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.